Literature DB >> 10218548

Antiphospholipid antibodies and thrombosis.

M Greaves1.   

Abstract

Antiphospholipid antibodies are associated with arterial and venous thrombosis, recurrent pregnancy loss, and thrombocytopenia. Although the antibodies have not been conclusively shown to be causal in thrombosis and miscarriage, they are useful laboratory markers for the antiphospholipid syndrome. The identification of the syndrome is clinically important because of the risk of recurrent thrombosis and the need for antithrombotic therapy in many cases. Diagnosis and treatment of antiphospholipid syndrome is difficult, however, because of the protean clinical manifestations and associations, limitations of existing laboratory tests for antiphospholipid antibodies, and the absence of evidence-based guidance on best management.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218548     DOI: 10.1016/S0140-6736(98)10362-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Novel expression of VCAM-1 on the mitral valve in a patient with primary antiphospholipid antibody syndrome.

Authors:  M Suguta; Y Hoshino; S Naito
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

3.  The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Authors:  R L Nachman
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

4.  A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999.

Authors:  R Al-Shahi; C P Warlow; G H Jansen; C J Frijns; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

Review 5.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.

Authors:  Yao-Hsu Yang; Kwan-Ki Hwang; John FitzGerald; Jennifer M Grossman; Mihaela Taylor; Bevra H Hahn; Pojen P Chen
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

7.  Endoscopically removed hepatolithiasis associated with cavernous transformation of the portal vein and antiphospholipid antibody syndrome.

Authors:  Keisuke Okudaira; Atsushi Kawaguchi; Takuya Inoue; Kazutoshi Hashiguchi; Yoshikazu Tsuzuki; Shigeaki Nagao; Kazuro Itoh; Soichiro Miura
Journal:  Dig Dis Sci       Date:  2006-10-24       Impact factor: 3.199

Review 8.  Diagnosis and management of patients with the antiphospholipid syndrome.

Authors:  B M Alving
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

9.  Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis.

Authors:  Jan Steffen Jürgensen; Ralf Kettritz; Wolfgang Schneider; Herbert Koop; Thorsten Sven Hildebrand; Ulrich Frei; Kai-Uwe Eckardt
Journal:  Rheumatol Int       Date:  2003-03-29       Impact factor: 2.631

10.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.